Cargando…

Lack of evidence for BCG vaccine protection from severe COVID-19

Detalles Bibliográficos
Autores principales:	Lindestam Arlehamn, Cecilia S., Sette, Alessandro, Peters, Bjoern
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2020
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568270/ https://www.ncbi.nlm.nih.gov/pubmed/32994350 http://dx.doi.org/10.1073/pnas.2016733117

Ejemplares similares

A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
por: Dijkman, Karin, et al.
Publicado: (2023)

Definition of CD4 Immunosignatures Associated with MTB
por: Lindestam Arlehamn, Cecilia S., et al.
Publicado: (2014)

CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature
por: Singhania, Akul, et al.
Publicado: (2021)

Imprinting of Gut-Homing Receptors on Mtb-Specific Th1* Cells Is Associated with Reduced Lung Homing after Gavage BCG Vaccination of Rhesus Macaques
por: Hoft, Stella G., et al.
Publicado: (2023)

Experimental validation of the RATE tool for inferring HLA restrictions of T cell epitopes
por: Paul, Sinu, et al.
Publicado: (2017)

The Challenge of Distinguishing Cell–Cell Complexes from Singlet Cells in Non‐Imaging Flow Cytometry and Single‐Cell Sorting
por: Burel, Julie G., et al.
Publicado: (2020)

Automatic Generation of Validated Specific Epitope Sets
por: Carrasco Pro, Sebastian, et al.
Publicado: (2015)

Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis
por: Burel, Julie G., et al.
Publicado: (2019)

BCG Vaccination Policy and Protection Against COVID-19
por: Meena, Jitendra, et al.
Publicado: (2020)

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
por: Garretti, Francesca, et al.
Publicado: (2019)

Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson’s Disease
por: Williams, Gregory P., et al.
Publicado: (2022)

What is the efficacy of BCG vaccination in the protection from COVID-19 in European countries?
por: Ghazvini, K., et al.
Publicado: (2021)

Classical CD4 T cells as the cornerstone of antimycobacterial immunity
por: Morgan, Jeffrey, et al.
Publicado: (2021)

COVID-19 Death and BCG Vaccination
por: Wiwanitkit, Viroj
Publicado: (2021)

A Review on T Cell Epitopes Identified Using Prediction and Cell-Mediated Immune Models for Mycobacterium tuberculosis and Bordetella pertussis
por: Tian, Yuan, et al.
Publicado: (2018)

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens
por: Marrama, Daniel, et al.
Publicado: (2022)

Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
por: Surenaud, Mathieu, et al.
Publicado: (2019)

Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany
por: Marín-Hernández, Daniela, et al.
Publicado: (2021)

BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
por: Escobar, Luis E., et al.
Publicado: (2020)

Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis
por: Du Bruyn, Elsa, et al.
Publicado: (2020)

BCG Protection Against COVID-19: Is it Reality or Illusion?
por: Sharqule, Inas K., et al.
Publicado: (2021)

Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile
por: Chihab, Leila Y., et al.
Publicado: (2022)

BCG vaccination induced protection from COVID-19
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021)

Limited recognition of Mycobacterium tuberculosis-infected macrophages by polyclonal CD4 and CD8 T cells from the lungs of infected mice
por: Patankar, Yash R., et al.
Publicado: (2019)

Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopes
por: Carrasco Pro, Sebastian, et al.
Publicado: (2018)

Protective role of intravesical BCG in COVID-19 severity
por: Gallegos, Héctor, et al.
Publicado: (2021)

Trials of BCG vaccine will test for covid-19 protection
por: Lawton, Graham
Publicado: (2020)

BCG Vaccine does not Protect Against COVID-19
por: Allam, Mohamed F., et al.
Publicado: (2020)

BCG Vaccination Protection Against COVID-19: Correspondence
por: Singh, Surjit, et al.
Publicado: (2021)

BCG Vaccine does not Protect Against COVID-19
por: Allam, Mohamed F., et al.
Publicado: (2020)

On BCG Vaccine Protection from COVID-19: A Review
por: Bagheri, Narges, et al.
Publicado: (2021)

Pseudomonas aeruginosa pilin activates the inflammasome
por: Lindestam Arlehamn, Cecilia S, et al.
Publicado: (2011)

BCG vaccination and COVID-19: Much ado about nothing?
por: Caminati, M., et al.
Publicado: (2020)

BCG vaccination and COVID-19: Was flattening the curve just an illusion?
por: Ricco’, M., et al.
Publicado: (2021)

Quantitative and Qualitative Perturbations of CD8(+) MAITs in Healthy Mycobacterium tuberculosis–Infected Individuals
por: Pomaznoy, Mikhail, et al.
Publicado: (2020)

BCG Vaccination Policy and Protection Against COVID-19: Correspondence
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2020)

TB infection and BCG vaccination: are we protected from COVID-19?
por: Madan, M., et al.
Publicado: (2020)

Multiple Consecutive Infections Might Explain the Lack of Protection by BCG
por: Cardona, Pere-Joan, et al.
Publicado: (2014)

MYCOBACTERIAL ABSCESSES AFTER BCG VACCINATION
por: Brennan, R, et al.
Publicado: (2019)

T Cell Responses to Neural Autoantigens Are Similar in Alzheimer’s Disease Patients and Age-Matched Healthy Controls
por: Dhanwani, Rekha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p6n1q5g6o1b7gn8h2g0rgb9s24